HELM Portugal announces an exclusive distribution agreement with CSPC Weisheng Pharmaceutical (Shijiazhuang) Co. Ltd.
HELM Portugal, part of the HELM Group and HELM’s Competence Center for European distribution of active pharmaceutical ingredients, announces an exclusive agreement with CSPC Weisheng Phramaceutical (Shijiazhuang) Co. Ltd. for the distribution of pharma grade Ascorbic Acid – Vitamin C for Europe. Our Pharma Grade Vitamin C can be used in various pharmaceutical, cosmetical, and nutritional applications.
Mr.Zhang Zheng, Executive President of CSPC Pharmaceutical Group Limited said “We are pleased to grow our European presence with pharma grade Vitamin C alongside HELM. With their technical and logistical expertise and their passion for the business, we will support our joint customers in their efforts to develop innovative and high-quality applications.”
“The Agreement builds on the longstanding and trustful relationship between CSPC and HELM. This new agreement is another important step to combine our strengths in serving our European customers with the highest quality ingredients.” said Sven Dankers, Managing Director of HELM Portugal. “We believe our customers will greatly benefit from this new set-up in their efforts to develop innovative products at the highest quality”.
About HELM
HELM Portugal is a subsidiary of HELM AG, Germany, a based family company established in 1900.
HELM is one of the world’s largest chemicals marketing companies. The Company secures access to the world’s key markets through its specific regional knowledge and over 100 subsidiaries, sales offices and participations in more than 30 countries. As a multifunctional marketing organization HELM is active in the chemicals industry, in the crop protection industry, in active pharmaceutical ingredients, pharmaceuticals and in the fertilizer industry.
About CSPC
CSPC Weisheng Pharmaceutical (Shijiazhuang) Co. Ltd. is part of CSPC Pharmaceutical Group Limited ("CSPC") (Stock code: 1093.HK),leading pharmaceutical group in China. Being one of the Hang Seng Index constituent stocks, the first pharmaceutical share since the past 50 years.
For more details, pls visit CSPC at http://www.e-cspc.com.